MOUNTAIN VIEW, Calif., June 29, 2016 /PRNewswire/ -- Based on its recent analysis of the consumer health and wellness industry, Frost & Sullivan recognizes Amino with the 2016 North America Frost & Sullivan Award for Visionary Innovation Leadership. Amino has firmly established its visionary leadership excellence through its data-driven consumer health platform to help patients make better healthcare decisions through superior doctor searches. Its outstanding strategic approach to extract and analyze healthcare insurance claims from a multitude of extremely fragmented data sources has placed it far ahead of many of its competitors in the healthcare industry.
Amino's consumer health platform offers interactive doctor selection and free appointment scheduling services that enable users to sort doctors based on their experience, as well as the users' individual preferences. The doctor search engine features a dynamic matching algorithm and search filters that provide an unbiased assessment of doctors based on their practice, location, gender, and other credentials critical to patients seeking specialized treatment or that have complex healthcare needs.
"Amino analyses a secure database of more than 5 billion healthcare interactions before matching patients with doctors who have treated similar health conditions," said Frost & Sullivan Research Analyst Dinesh Kumar. "Amino also takes the responsibility of booking an appointment with follow-up confirmations. As its doctor listings are non-sponsored and advertisement-free, users feel confident about making important healthcare decisions."
Amino's comprehensive database includes nearly every practicing doctor (approximately 893,000) in the United States and a vast search engine powered by healthcare transaction data covering the experiences of 188 million Americans. Furthermore, it takes into account data for over 800 medical conditions, procedures, and specialties during a personalized search. In many instances, Amino even surfaces actionable, physician-level information such as a doctor's sub-specialty based on their real-life practice patterns.
Moreover, Amino has engineered its platforms in a way that makes transparent sensitive health data that remained in-silo for years. In addition to its commercial claims database of over 5 billion claims, it is the first for-profit company to be approved by Medicare to obtain national, physician-level data on more than 3 billion Medicare claims annually.
The platform's most important value-added benefit is its customer centricity. Amino has broken down financial barriers, making all information and products freely available on Amino.com. This way, it caters to a wide range of health care needs and optimizes for efficiency, safety, and outcomes.
"Amino stands out as one of the few companies dedicated to transforming healthcare consumer engagement with next-generation interactive solutions that use data analytics and business intelligence concepts," noted Kumar. "Despite tough competition from industry-leading vendors that offer similar services, Amino's data-driven, unbiased, and consumer-centric doctor search platform has proven to be a solid market differentiator in an increasingly crowded landscape."
Each year, Frost & Sullivan presents this award to the company that has demonstrated the understanding to leverage global Mega Trends, and integrate the vision into processes to achieve strategic excellence. The award recognizes the efficacy of the recipient's innovative process and the impact it has on business and society at large.
Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.
Amino aims to connect everyone to the best health care possible. Powered by a comprehensive database that includes nearly every practicing doctor in America and experiences from more than 188 million patients, Amino's service empowers people to make confident decisions about their health care, starting with the doctors they choose. The company is based in San Francisco and is backed by Accel Partners, Charles River Ventures, Rock Health, and notable individual investors. For more information, please visit: amino.com.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
- The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics, and emerging economies?
P: +44 (0) 207.343.8314
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/frost--sullivan-lauds-aminos-exceptional-technology-that-empowers-patients-to-make-better-healthcare-decisions-300291377.html
SOURCE Frost & Sullivan